---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-166855"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T01:06:51.773386+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Agios stockholders approve 2023 Stock Incentive Plan; elect three Class I directors

## Summary
- Elected Rahul Ballal, Brian Goff, and Cynthia Smith as Class I directors for terms expiring at the 2026 annual meeting.
- 2023 Stock Incentive Plan approved with 27,268,226 votes for, 23,635,666 against, and 25,531 abstentions.
- Non-binding advisory vote on named executive officer compensation passed (46,289,192 for, 4,630,627 against).
- PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2023 (50,024,364 for, 1,876,012 against).

## SEC filing metadata
- accession: 0001193125-23-166855
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/d415331d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-166855
- JSON: https://secwatch.observer/filing/0001193125-23-166855.json
- Plain text: https://secwatch.observer/filing/0001193125-23-166855.txt

## Key facts
- Shareholder Votes
  AGIOS PHARMACEUTICALS, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-04-26 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-04-26
  source text: The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the current fiscal year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm
- Shareholder Votes
  AGIOS PHARMACEUTICALS, INC. shareholders approved Approval of the 2023 Plan at the 2023-04-26 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-04-26
  source text: The Company’s stockholders approved the 2023 Plan.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm
- Shareholder Votes
  AGIOS PHARMACEUTICALS, INC. shareholders approved Election of Class I directors at the 2023-04-26 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-04-26
  source text: The Company’s stockholders elected Rahul Ballal, Brian Goff and Cynthia Smith as Class I directors, each to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm
- Shareholder Votes
  AGIOS PHARMACEUTICALS, INC. shareholders approved Non-binding advisory vote on compensation paid to named executive officers at the 2023-04-26 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-04-26
  source text: The Company’s stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1439222/000119312523166855/0001193125-23-166855-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.